Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5803_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
16. Waldhausen JH, Tapper D, Sawin RS. Minimally in­vasive surgery and clinical decision-making for pe­diatric malignancy. Surg Endosc. 2000;14(3):250–3.
Hassan SF, Mathur S, Magliaro TJ, et al. Needle
17. core vs open biopsy for diagnosis of intermediate­and high-risk neuroblastoma in children. J Pediatr Surg. 2012;47(6):1261–6.
18.
Shin HJ, Amaral JG, Armstrong D, Chait PG,
et
al. Image-guided percutaneous biopsy of mus­culoskeletal lesions in children. 2007;37(4):362–9.
19. Sebire NJ, Roebuck DJ. Pathological diagnosis of paediatric tumours from image-guided core biopsies: a systemic review. Pediatr Radiol. 2006;36(5):426–31.
20. Sköldenberg EG, Jakobson AA, Elvin A, et al. Di­agnosing childhood tumors: a review of 147 cut­ting needle biopsies in 110 children. J Pediatr Surg. 2002;37(1):50–6.
21.
Willman JH, White
needle biopsy: strengths and limitations in evalu­ation of masses. Pediatr Dev Pathol. 2001;4(1): 46–52.
Garrett KM, Fuller CE, Santana
22. taneous biopsy of pediatric solid tumors. Cancer 2005;104(3):644–52.
Ovchinsky N, Moreira RK, Lefkowitch JH, et al.
23. Liver biopsy in modern clinical practice: atric point-of-view. Adv Anat Pathol. 2012;19(4): 250–62.
24. Dezőfi A, Baumann U, Dhawan A, Durmaz O,
Liver biopsy in children: position paper of the ES­PGHAN hepatology committee. J Pediatr Gastroen­terol Nutr. 2014; Epub ahead of print.
25. Dezőfi A, Knrisely AS. Liver biopsy in children
2014; who, whom, what, when, where, why? Clin Res Hepatol Gastroenterol. 2014;38(4):395–8.
K, Coffin CM. Pediatric core
Pediatr Radiol.
needle
al. Percu-
VM, et
a pedi-
et
al.
26.
Bakr A, Eid R, Sarhan A, et al. Fifteen years of kidey
biopsies in children: Kidney Dis Transpl. 2014;25(6):1321–7.
27. Feneberg R, Schaefer F, Zieger B, et al. Percutane­ous renal biopsy in children: a 27-year experience. Nephron. 1998;79(4):438–46.
Franke M, Kramarczyk A, Taylan C, et al.
28. Ultrasound-guided percutaneous renal biopsy in 295 children and adolescents: role of ultrasound and analysis of complications. PLoS ONE. 2014;9(12): e1
14737 eCollection.
29.
Brachemi S, Bollée G. Renal biopsy practice: what
is the gold standard? 287–94.
30. Zoeller G, Pekrun A, Lakomek M, et al. Wilms’ tumor: the problem of diagnostic accuracy in children undergoing preoperative chemotherapy without histological tumor verification. J Urol. 1994;151(1):169–71.
31.
Colombo M, Del Ninno E, de Franchis R, et al.
Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the menghini nee­dle for diagnosis of cirrhosis. Gastroenterology. 1988;95(2):487–9.
Goldner F. Comparison of
32.
.
and Tru-Cut needles in diagnosing cirrhosis. J Clin Gastroenterol. 1979;1(3):229–31.
Hatfield MK, Beres RA, Sane SS, et al. Percutane-
33.
ous imaging-guided solid organ core needle biopsy: coaxial versus noncoaxial method. AJR Am J Roentgenol. 2008;190(2):413–7.
34.
Short SS, Papillon S, Hunter CJ, et al. Percutane-
ous liver biopsy: pathologic diagnosis and compli­cations in children. J Pediatr Gastroenterol Nutr. 2013;57(5):644–8.
a single center in Egypt. Saudi J
World J Nephrol. 2014;3(4):
the Menghini, Klatskin
22719 Core Biopsy of Masses and Solid Organs
Fine Needle Aspiration (FNA) of the Thyroid Gland
Ranjith Vellody
20
Introduction
Thyroid cancer is the most common endocrine malignancy in children [1] and is increasing in both incidence and prevalence. Risk factors for thyroid cancer in children are radiation exposure (such as prior therapy for lymphoma), female gender, and family history [2]. Children have the same types of thyroid cancer as seen in adults (papillary, follicular, medullary, anaplastic); however, children often present with more ad­vanced disease [2]. Data have shown that thyroid nodules in children are more likely to be malig­nant than adults. In spite of this, children have a better prognosis. Factors which worsen the prog­nosis include male sex, nonsurgical treatment, non-papillary type cancer, and patients with dis­tant metastases [3].
Guidelines from Society of Radiologists in Ultrasound (SRU) and the American Association of Clinical Endocrinologists do not specifically mention the management of thyroid nodules in children [4, 5]. However, the revised 2009 guide­lines from the American Thyroid Association do suggest that the management of pediatric thyroid nodules should be the same as adults [3].
A detailed clinical history and physical ex­amination are performed with an emphasis on
R. Vellody () Department of Radiology, University of Michigan, 1500 E. Medical Center Drive, Room UH B1-0502, Ann Arbor, MI 48109, USA e-mail: ranjithv@med.umich.edu
© Springer International Publishing Switzerland 2016 S. Scholz, M. D. Jarboe (eds.), Diagnostic and Interventional Ultrasound in Pediatrics and Pediatric Surgery, DOI 10.1007/978-3-319-21699-7_20
detecting signs and symptoms of thyroid disease. Laboratory values including a serum TSH are then drawn. If TSH levels are normal or high, a diagnostic ultrasound may be performed. Sev­eral ultrasound characteristics of the thyroid gland are important to evaluate. These include whether the disease process is diffuse versus focal, the number and size of the lesions present, and whether lesions are solid, cystic, or mixed (Fig. 20.1 and 20.2). In addition, the presence of calcifications, colloid, associated vascularity, and levels of pathologically enlarged lymph nodes should be documented. Typically, descriptors in the thyroid ultrasound report suggesting that a process may not be benign include the presence of macrocalcifications or microcalcifications, ab­sence of a halo, increased vascularity, solid com­position, and irregular margins (Figs. 20.3, 20.4 and 20.5).
Based on the SRU consensus statement, fine needle aspiration (FNA) is suggested for a thy­roid nodule of 1.0 cm or larger if microcalfcifica­tions are present, 1.5 cm or larger if the nodule is solid with coarse calcifications, 2 cm with mixed solid and cystic components, or nodules that have substantial growth over an interval period [6]. As reflected in the SRU guidelines, ultrasound char­acteristics are more important than size when de­termining whether a nodule should be sampled.
The cytopathology result of the FNA deter­mines whether observation, repeat FNA, or sur­gery should be performed. With respect to the cytopathology result, the Bethesda Classification System for Reporting Thyroid Cytopathology
229
230 R. Vellody
Fig. 20.1 Transverse ultrasound image of the right lobe demonstrates a thin-walled anechoic structure with poste­rior acoustic enhancement in the thyroid gland. This is a simple benign cyst
Fig. 20.3 a Transverse thyroid ultrasound image reveals microcalcifications (arrow) within a solid nodule in the left lobe of the thyroid. Fine needle aspiration of the le­sion was significant for papillary thyroid carcinoma. b Transverse image of lymph node in the right neck ad­jacent to the carotid artery in the same patient. Note the similar sonographic appearance to the primary thyroid lesion (arrow)
Fig. 20.2 Transverse ultrasound image of the right lobe of the thyroid demonstrating a mixed solid and cystic nodule. Targeted FNA of the solid portion of the lesion revealed papillary thyroid carcinoma
allows for standardization which in turn dic­tates management [7]. Every FNA report groups the cytopathology into six distinct categories. Each category has an associated risk for malig­nancy and a recommended management scheme (Table 20.1).
Fig. 20.4 Coarse calcifications within a thyroid nod- ule. Note the posterior shadowing from the calcifications (arrow). FNA revealed papillary cancer
23120 Fine Needle Aspiration (FNA) of the Thyroid Gland
inherent risks and every case should undergo an appropriate risk/benefit analysis. However, it is best to err on the side of increased patient comfort and hence decreased patient motion as adjacent structures can be inadvertently damaged even with a small-gauge needle.
Some practitioners perform FNA of thyroid without ultrasound. Although ultrasound guid­ance may add slightly to the cost and length of the procedure, it is felt to provide more accurate diagnostic information. This is particularly true when nodules cannot be palpated, when there is some alteration in anatomy, and when a specific thyroid nodule needs to be sampled in the set­ting of multiple nodules. Additionally, ultrasound allows for targeting of the solid components of a lesion that has mixed solid and cystic charac­teristics and allows for the visualization of larger vasculature that should be avoided.
Pre-procedural Management
The most important aspect of pre-procedural management is confirming that there is a docu­mented indication for the biopsy. All prior im-
Fig. 20.5 a Transverse ultrasound images of the thyroid in a 10-year-old female. A dominant nodule path proven to be papillary thyroid carcinoma is noted within the right lobe of the thyroid. b Color Doppler demonstrates hyper­vascularity of the lesion
aging studies should be reviewed. Most practi­tioners agree that anticoagulants, including anti­platelet agents, should be held for 4–7 days prior to the FNA procedure. In some instances, anti­platelet agents may be difficult to hold. Thyroid lesions can still be safely biopsied in this clinical
FNA in children presents a unique challenge as opposed to adults. While most adults can lie still for an FNA, children may require local anesthesia, intravenous conscious sedation, or even general anesthesia. Anesthesia does carry
Table 20.1  The Bethesda classification system for thyroid malignancy
Classification Risk of malignancy (%) Management
Nondiagnostic 1–4 Repeat FNA Benign <5 Follow up ultrasound in 6–18 months Follicular lesion of uncertain significance 5–15 Follow up ultrasound +/− repeat FNA in 3–6
Follicular neoplasm, Hürthle cell neoplasm 20–30 Surgical lobectomy Suspicious for papillary thyroid cancer 60–75 Thyroid lobectomy/total thyroidectomy Papillary thyroid cancer 98 Total thyroidectomy
FNA Fine needle aspiration
setting as long as the procedure is meticulously performed. Informed consent with documenta­tion of the risks of the procedure should be ob­tained from the patient or legal guardian. It is also prudent to discuss each case individually with the
months
232 R. Vellody
anesthesia provider to determine whether local anesthetic alone, intravenous sedation, or general endotracheal anesthesia will be required. If the institution has the capability, having an on-site cytopathologist during the procedure can elimi­nate unnecessary needle passes through the thy­roid lesion and limit the amount of nondiagnostic biopsies.
Technique
Once the child is in the procedure room, patient verification is performed. A preliminary thyroid ultrasound should be performed at this time to document the continued presence of the lesion that is to be biopsied. The patient should then be anesthetized according to the previously deter­mined plan. The patient is positioned with their neck in extension, usually with a rolled towel or small pillow underneath the shoulder blades [8].
With a high frequency probe (7.5–15 MHz), the nodule of interest is identified and an over­view of the surrounding anatomy is obtained [4]. Using color Doppler, large surrounding vascular structures are noted. An appropriate path for the biopsy needle is determined to avoid vascular structures and traverse as little as normal tissue as possible. The neck is prepped and draped in standard sterile fashion. At this point, the ultra­sound probe should be covered with a sterile probe cover containing ultrasound gel.
Although many ultrasound-guided procedures require the use of ultrasound gel on the outside of the probe cover in order to maximize image quality, gel can get stuck in the needle bore and can interfere with the cytology assessment by causing precipitation on Wright staining [9]. For this reason and because the thyroid is a superfi­cial structure, FNA can be performed in an alter­native manner using only an antiseptic solution such as betadine to achieve adequate skin contact with the ultrasound probe. It should be noted that ultrasound gel can still be used as long as the op­erator is aware of the potential downsides.
Because the thyroid gland is highly vascular, a small gauge needle is recommended for aspi­ration. There are different recommendations for
the gauge of a needle ranging between 22 and 27 gauge [4, 9, 10, 12]. Any needle gauge less than 27 is too small, given that the diameter of the fol­licular cell nucleus is in the 200 µm range and the inside diameter of a 25- and 27-gauge needle is between 191 and 241 µm [9]. Furthermore, core biopsies of the thyroid gland are not part of routine practice and are rarely performed due to the potential increased risk of bleeding complica­tions.
While operators at many institutions use local anesthesia, it is not recommended by the Nation­al Committee for Clinical Laboratory Standards because it can cause more pain than the FNA it­self. Moreover, it can obscure cellular detail on pathology and anatomic detail during instillation [11]. However, local anesthesia does offer the benefit of pain relief during and after the pro­cedure, allowing for a better patient experience. Typically, this is done using a 25-gauge needle and should be used in the subcutaneous fat, not the reticular dermis, to infiltrate dermal nerves [9]. The amount of anesthetic that can be admin­istered varies depending upon the type of medica­tion used, whether it is mixed with epinephrine, and the weight of the patient. Additionally, an anesthetic cream such as EMLA cream, a spray formulation or ice can be used as an anesthetic. The former has a vasoconstrictor effect and leads to less hemodilution of the aspirate [9, 12].
Under ultrasound guidance, utilizing the free hand technique or an ultrasound guide, the needle is slowly advanced toward the superficial margin of the nodule. Several forward and back oscilla­tions are made with the needle through the lesion (Fig. 20.6). This motion allows for more mate­rial to enter the bore of the needle and become trapped for extraction. The intralesional dwell time during this portion of the procedure should be 2–5 s. Suction can be applied to the needle with a syringe during the aspiration but is not necessary as there is already native suction pro­vided by the existing surface tension in the nod­ule [13, 14]. The literature suggests that suction is more convenient, however, it is not does not provide a better diagnostic yield when compared to using no suction [13, 14].
23320 Fine Needle Aspiration (FNA) of the Thyroid Gland
Fig. 20.6 Intraprocedural transverse ultrasound image of a thyroid fine needle aspiration. Note the echogenic 25-gauge needle (arrow) within a dominant right thyroid nodule
Some operators feel more needle passes through the lesion can increase the diagnostic yield. However, there is some literature to sug­gest that more than ten needle passes during sampling can increase the risk of hematoma formation [10]. If blood is identified within the needle during sampling the operator should not be alarmed, since this only means that the low­er-viscosity blood has preferentially entered the needle over the higher-viscosity material. Blood identified within the needle can be due to exces­sive suction or a long dwell time of the needle within the lesion [9, 11].
The nodule of interest is sampled and the nee­dle is given to the cytopathologist for analysis. Typically, three to five passes are performed at the beginning of the procedure and given to the cytopathologist at one time, since preparation of the material for viewing under the microscope can take a few minutes. If no cytopathologist is present, the needle can be placed bevel down and the aspirate smeared onto a slide and submitted to cytopathology [11]. When preparing your own slides, using a one step method is preferable by using one slide to hold the sample and the sec­ond to spread it. It can be difficult to know when enough material is present for diagnosis when an on-site cytopathologist is not present.
A thorough ultrasound of the neck is per­formed after the procedure to look for a hema­toma [10]. An ice pack or acetaminophen is the preferred method of analgesia post procedure. Discharge instructions should include notify­ing the clinician for any signs of neck swelling, shortness of breath, redness, or discharge from the FNA site [10].
Post-procedural Complications
Complications that can be seen after a thyroid FNA include pain, bruising, and hematoma around the FNA site. Rarely, an infection may be encoun­tered. Allergic reactions to local anesthetics are rare and the main treatment is antihistamines. The recurrent laryngeal nerve is within the region of the thyroid, therefore puncture is possible, how­ever this is extremely rare [11, 15]. Large blood vessel transgression can occur with the needle, but with good ultrasound imaging and color Dop­pler this is also extremely rare. Another rare com­plication is tumor seeding which has been noted in 12 cases [16]. Tumor seeding may be prevented by limiting the number of needle passes, making sure the needle does not transgress deep to the le­sion and using smaller needles for the FNA.
The main cause of inadequate samples is other substances such as ultrasound gel or blood pre­dominating the sample. This can be minimized by limiting the use of ultrasound gel or suction and having on-site cytopathologist to review the sample. Other causes include performing a bi­opsy on a predominantly cystic or excessively vascular nodule. Although studies evaluating the efficacy of FNA of the thyroid in children are not well established, many centers find that di­agnostic samples can be obtained in over 90 % of patients. Some authors have concluded that the efficacy is less for nodules less than 5 mm [17].
Summary
FNA of suspicious thyroid nodules in children is an important part in the medical evaluation of these patients. As research continues to evolve,
234 R. Vellody
it is important for clinicians to know what con­stitutes best practice with respect to technique. Doing so will allow for maximum yield, less dis­comfort to the patient, and less inconvenience to the patient’s family.
References
1. Hogan A. The incidence of pediatric thyroid can­cer is increasing and is higher in girls than in boys and may have an adverse outcome. Clin Thyroidol. 2009;21(10):10–2.
2.
Önder A. Approach to
adolescents. Turk J Pediatr. 2014;56:219–25.
Cooper D, et al. Revised American thyroid associa-
3. tion
management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.
Kim M, et al. US-guided fine-needle aspiration of thy-
4. roid nodules: indications, techniques, results. Radio­graphics. 2008;28(7):1869–86.
5. Frates M. Management of thyroid nodules detected at US society of radiologists in ultrasound consensus con­ference statement. Ultrasound Q. 2006;22(4):231–40.
6. Frates M. Management of thyroid nodules detected at us: society of radiologists in ultrasound consensus con­ference statement. Radiology
Cibas E, Ali S The
7. thyroid cytopathology. Thyroid. 2009;19:1159–1165.
Dhurandhar N, et al. Fine needle aspiration biopsy
8. (FNAB) techniques; approved guideline-second edi tion. Clinical and Laboratory Standards Institute. 2003;23(27):3.
thyroid nodules in children and
. 2005;237(3):794–800.
bethesda system for reporting
9. Pitman M, et al. Techniques for thyroid FNA: opsis of the national cancer institute thyroid fine-nee­dle aspiration state of the science conference. Diagn Cytopathol. 2008;36(6):407–24.
Dogra V, Saad W
10. thyroid nodules. In: Ultrasound-guided procedures.
ed. New York: Thieme; 2010. pp. 67–72.
2nd
NCCLS. Fine Needle Aspiration Biopsy (FNAB)
11. T
echniques; Approved Guideline-Second Edition. NCCLS document GP20-A2 [ISBN 1-56238-509-7]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2003.
12. Oertel Y. Fine-needle aspiration of the thyroid: tech­nique and terminology. Endocrinol Metab Clin North Am. 2007;36:737–51.
Pothier D, Narula A. (2006). Should we apply suc-
13.
tion during ne
systematic review and meta-analysis. Ann R Coll Surg Engl. 88(7):643–45.
Maurya AK, Mehta A, Mani NS, Nijhawan VS,
14. Batra R. Comparison of aspiration
tion techniques in ne-needle cytology of thyroid
lesions. J Cytol/Indian Acad Cytol. 2010;27(2):51–4. doi:10.4103/0970-9371.70737.
15. Tomoda C, Takamura Y, Ito Y, Miya A, Miyauchi A. Transient vocal cord paralysis after ne-nee­dle aspiration biopsy of thyroid tumor. Thyroid. 2006;16(7):697–9.
Polyzos S, et al. A systematic review of cases
16.
ing needle tract seeding following thyroid ne needle
biopsy. World J Surg. 2010;34:844–51.
Kim D, et al. Ultrasound-guided ne-needle aspira-
17. tion
biopsy of thyroid nodules: comparison in efcacy
according to nodule size. Thyroid. 2009;19(1):27–31.
-
. Fine-needle aspiration biopsy of
needle cytology of thyroid lesions? A
vs non-aspira-
A syn-
report-
Diagnostic and Therapeutic Drainage
Samir K. Gadepalli
21
Introduction
There are many different types of collections of fluid (e.g., those in a cavity, those after surgery, those that are congenital); the approach to diag­nosis or therapy may be different based on the type and location. Being able to categorize fluid collections by type and location in the body is the first step. These fluid collections can occur at any part of the body and knowing your anatomy is a key way to avoid any complications.
The next step is preparation which leads to a series of questions: Do I have all the equipment, does this need to be sterile, does the primary team managing the patient want the fluid sent for special things including cultures, is this a recur­rence, do we need to perform a sclerosis, is this in conjunction with a biopsy, is ultrasound the cor­rect image guidance modality for this instance. Knowing the history and doing a thorough physi­cal checkup is still important prior to picking up the ultrasound. A patient with allergies, having severe anxiety to the procedure, or just after a meal, could seriously hinder the ability to per­form an ultrasound. As interventional ultrasound is an adjunct to clinical care—the provider car­ing for the patient and the person performing the ultrasound-guided procedure may be different—
S. K. Gadepalli () Division of Pediatric Surgery, Department of Surgery, C.S. Mott Children’s Hospital, 1540 East Hospital Drive, SPC 4211, Ann Arbor, MI 48108, USA e-mail: samirg@med.umich.edu
© Springer International Publishing Switzerland 2016 S. Scholz, M. D. Jarboe (eds.), Diagnostic and Interventional Ultrasound in Pediatrics and Pediatric Surgery, DOI 10.1007/978-3-319-21699-7_21
leading to a fragmentation in care that could lead to communication issues.
Finally, technical considerations, such as hav­ing more than one ultrasound probe, are essen­tial. The diagnostic and therapeutic probes used for ultrasound do not have to be the same. For example, identifying the collection may be bet­ter with a curved probe, but following the needle into the cavity may be better with a linear probe. Furthermore, having a range of drainage cathe­ters, guidewires, and dilators is crucial to the suc­cess of a drainage procedure. Moreover, the path to the collection does not have to be directly per­cutaneous and may need to traverse an organ. For example, accessing the gallbladder through the liver parenchyma or a pelvic collection through a transrectal approach often is superior to other op­tions. Finally, having the ability to inject the col­lection with contrast and monitoring this using fluoroscopy should not be underestimated.
In this chapter, we focus on general prin­ciples as briefly outlined above, then focus on a transrectal approach to drainage, after which we discuss special circumstances where there is literature to support a specific strategy. For ex­ample with ascites, make sure to have albumin available or know if the patient has significant liver disease; or with a pleural effusion, use of tissue plasminogen activator (TPA) to prevent a recurrence versus needing to send samples to rule out malignancy.
235
236 S. K. Gadepalli
General Principles
Fluid collections can be differentiated into vari­ous types based on history and anatomic location. Categorizing them based on history and location helps with management by using a diagnostic or therapeutic algorithm. The following is an ex­ample of various ways a collection can be cat­egorized:
1. Collections in general: unknown, malignant, infectious, lymphatic
2. Abscesses: postoperative, chest, mediastinal, abdominal, pelvic
3. Gastrointestinal (GI): pancreatic, splenic, foregut/duplication, chronic cholecystitis, hy­datid cyst
4. Urologic: hydronephrosis, suprapubic cath­eter placement
Prior to drainage of a collection, the indica­tions must be reviewed, coagulopathy must be excluded or treated, and the appropriate imag­ing modality must be chosen [1]. The diagnostic approach to fluid collections starts with a good history and location of the lesion. If the patient has a history of malignancy or risk factors that increase the risk for a malignancy, the identifica­tion of a collection, such as a pleural effusion, can be a marker of the malignancy. Furthermore, qualities of a collection, such as the percentage of solid material, can differentiate a cystic collec­tion. Knowing the likelihood of a malignancy is important in the approach to drainage of a collec­tion as the tract used to sample the fluid can be a potential pathway for the spread of the disease.
Similarly, the sampling of the collection can
be diagnostic, therapeutic, or both. Therefore, having a general framework to approach the fluid is useful to prevent additional procedures or an­esthetics. As there is always a risk in the aspira­tion of a collection, combining procedures into one setting can mitigate further risks. For exam­ple, injection of a sclerosant into the cavity dur­ing drainage of a lymphatic collection prevents recurrence of the collection and, concomitantly, an additional procedure.
Drainage of a fluid collection should only be
performed when there is [2]: a suspicion of infec-
tion, a need for fluid characterization, or symp-
toms that warrant drainage. “The basic indication
for needle aspiration is to confirm the radiologi­cal diagnosis of an abscess because the radiologi­cal signs may not distinguish amongst various types of fluid collection including abscess, he­matoma, urinoma, biloma, lymphocele, seroma, and loculated ascites. The main indications for catheter drainage include treatment or palliation of sepsis associated with an infected fluid collec­tion, and alleviation of the symptoms that may be caused by fluid collections by virtue of their
size, like pancreatic pseudocele or lymphocele”
[1]. Figure 21.1 demonstrates needle entry into a fluid collection of unknown etiology for diagnos­tic purposes.
Informed consent following a thorough dis­cussion with the patient is mandatory for any invasive procedure. Rarely are the procedures emergent and the expectations of the patients and primary-care providers need to be assessed prior to performing the procedure. Identification of the indications, approach to drainage, choosing the appropriate imaging modality, specific diagnos­tic tests on the drainage, and therapeutic options should all be discussed at this time.
In diagnostic or therapeutic drainage, the steps are fairly simple though difficult to execute with­out sufficient practice. The collection is identi­fied using an ultrasound probe (as mentioned earlier, the probe used to initially find the collec­tion and that used for targeting drainage may be different). Using ultrasound guidance, the collec-
Fig. 21.1 Figure represents needle entry into a collection of unknown etiology using a curved probe for guidance
23721 Diagnostic and Therapeutic Drainage
Fig. 21.2 a Figure represents needle entry into a locu- lated abscess cavity with multiple septations. b Figure represents needle connecting multiple loculated collec­tions by breaking up the septations under visualization.
tion is approached using an 18- or 22-gauge entry needle based on the depth and size of the fluid. Advancing the needle in line with the ultrasound transducer provides excellent visualization of the entire needle and the target collection simultane­ously. This improves safety and maneuverability in advancing the needle. If purulent fluid is aspi­rated, it is sent for culture; of note, immunocom­promised patients may have bacteria or fungal collections without evidence of an immune re­sponse. Keep in mind that a Gram stain may fail to grow any organisms if the patient has already received antimicrobial therapy. Furthermore, use of a needle without the syringe attached can be a useful technique to facilitate guiding the needle into the cavity without the added weight of the syringe. The syringe can be attached once entry into the cavity can be confirmed by imaging. Based on the thickness of the fluid, the needle
may need to be “upsized” prior to drainage of the
contents.
To “upsize” the needle, a guidewire can be
inserted with serial dilation over the guidewire using a Seldinger technique. A 0.010- or 0.018­in. wire can be placed through the 22-gauge nee­dle whereas a 0.035 guidewire can be inserted through an 18-gauge entry needle. When using larger dilators, we routinely exchange a thinner guidewire to a larger diameter and stiffer wire to provide a stiff backbone for the dilator to travel over preventing dislodgment and errant passage of the dilator. Furthermore, the needle and guide­wire exchange is easier to accomplish with the cavity filled with fluid as there is more resistance on the wall to prevent dislodgement as well as prevent inadvertent entry through the opposite wall. If the fluid within a cavity has already been
c Figure represents abscess cavity being drained by the pigtail catheter that is now in place. The abscess is ir­rigated with saline and collapsed down at the end of the procedure
evacuated for diagnosis, irrigation with saline can be used to refill the area and help with the needle and guidewire exchange. Once a drain­age cathether has been inserted into the cavity, we routinely use ultrasound to confirm adequate drainage of the cavity and assess for additional located collections that were not initially noted or were inadequately drained. Although, the largest possible drainage catheter is generally used, there is no difference in recurrence, drainage time, and complications [3]. Figure 21.2 demonstrates evacuation of a loculated abscess by breaking up septations using the needle and placement of a pigtail for irrigation and drainage.
The management of a drain when placed should be standard for each institution. Drains can be placed to bulb or gravity drainage based on the expected quality and quantity of output. They should be ideally flushed with saline daily and removed in about 1–3 days when the output is less than 10 ml/day or 5 ml/day in infants [2]. While a drain is in place, antibiotics should be considered if there is a risk of translocation based on host factors, if there is adjacent foreign mate­rial such as an implant, or if the output is pre­sumptively infectious.
Ultrasound has become the imaging modal­ity of choice for many interventions with the advent of high-resolution, wide-angle probes. Ultrasound also offers the unique advantages of portability, immediate availability, and flexibil­ity, owing in part to the wide range of transduc­ers now available. Ultrasound probes have been specifically designed to guide the biopsy of small lesions, allow precise control of biopsy instru­ments, and provide direct, real-time visualization of successful target lesion biopsies. Moreover,